Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,739 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07584889RecruitingPhase 1/Phase 2
CAR-T Cell Therapy for Relapsed Blood Cancers
This trial tests a new type of immune cell therapy (CAR-T cells) designed to fight blood cancers that have come back or stopped responding to standard treatments. The therapy uses your own immune cells, which are modified in a lab to better recognize and attack cancer cells.
Shenzhen, Other (Non U.s.)Ages 18–75 - NCT07585370Recruiting
Long-term Safety and Effectiveness of Shingles Vaccine
This study follows up with people who received an experimental shingles vaccine (a live, weakened form of the virus) in a previous trial from 2020–2021. Researchers want to understand how well the vaccine continues to protect against shingles over time.
Nanjing, JiangsuAges 40 years+ - NCT07585981Recruiting
Budesonide capsules for IgA kidney disease
This trial tests whether a special steroid capsule called budesonide can help treat IgA nephropathy, a kidney disease where your immune system damages the kidneys. You would take this medication along with standard care to see if it slows kidney damage and reduces protein in your urine.
BeijingAges 18 years+ - NCT07588230Recruiting
Nerve Block for Minimally Invasive Heart Valve Surgery Pain
This study tests a targeted nerve block (pain-numbing injection) to help manage pain after minimally invasive heart valve surgery. Researchers want to see if this technique reduces pain and the need for opioid medications during recovery.
Diyarbakır, Outside of the USAges 18–75 - NCT07588438RecruitingPhase 4
Tirzepatide effectiveness and safety for diabetes and weight loss in Paraguay
This study tests how well and safely tirzepatide (a new injectable medication) works in real-world conditions for people with type 2 diabetes or obesity in Paraguay. The medication helps lower blood sugar and reduce weight.
AsunciónAges 18–70 - NCT07589322Recruiting
How GLP-1 drugs reshape fat and metabolism
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
TaipeiAges 20–65 - NCT07590362Recruiting
Testing breathing readiness measures in ventilated COPD patients
This study compares two methods of measuring whether patients with COPD who are on breathing machines are ready to breathe on their own. The goal is to find the best way to predict which patients can successfully come off the ventilator.
Sohag, Sohag GovernorateAges 18 years+ - NCT07590986Recruiting
Finding immune markers in blood cell disorders
This research study looks for specific immune system clues in patients with myeloproliferative neoplasms—rare blood disorders where your bone marrow produces too many blood cells. By identifying these markers, researchers hope to better understand and eventually treat these conditions.
Brussels, WoluweAges 18 years+ - NCT07591012Recruiting
Probiotic Supplements for Ulcerative Colitis Remission
This trial tests whether taking sodium butyrate (a short-chain fatty acid) and a specific probiotic yeast called Kluyveromyces marxianus can help keep ulcerative colitis in remission and prevent flare-ups. You'd need to be in remission (symptom-free with no active inflammation) when you start.
PadovaAges 18–75 - NCT07591246Recruiting
Exercise Program for PCOS With Fatty Pancreas and Thyroid Issues
This study tests whether a structured exercise program can help women with PCOS (a hormonal condition), fatty pancreas, and early thyroid problems. The goal is to see if physical activity improves these conditions and reduces symptoms.
GizaAges 20–40 - NCT07591649RecruitingPhase 1/Phase 2
NK cells for high-risk blood cancers before transplant
This study tests a new type of immune cell therapy (called AdaptNK cells) for patients with high-risk myeloid diseases (blood cancers affecting bone marrow cells) who are preparing for a stem cell transplant. The goal is to help control the cancer and prepare your body for the transplant.
Minneapolis, MinnesotaAges 18 years+ - NCT07591987Recruiting
Breathing Techniques to Reduce Shortness of Breath After Heart Surgery
This study tests whether special breathing exercises can help reduce shortness of breath and improve heart and lung function in patients recovering from open-heart surgery. You would learn and practice these breathing techniques before and after your surgery.
Baghdad, Baghdad GovernorateAges 18–75 - NCT07592962Recruiting
Long-term Health Study of Lishui City Residents
This study follows healthy adults in Lishui City over time to understand how people stay healthy and live longer. Researchers will collect health information and track your wellbeing to identify factors that contribute to a long, healthy life.
Lishui, ZhejiangAges 30–80 - NCT07593885Recruiting
Artelac Complete versus VISMED MULTI for severe dry eye
This study compares two preservative-free eye drops designed to treat moderate to severe dry eye disease. It evaluates which product works better and is safer for people whose dry eyes are caused by conditions like Sjögren's disease, autoimmune blistering disorders, or damaged tear glands.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT07596394Recruiting
Registry of Catheter-Based Aortic Valve Replacements
This registry collects information about patients who receive a new valve inserted through a catheter (a thin tube) rather than open surgery. It tracks how well the procedure works and any side effects to help doctors understand the long-term safety and effectiveness of this less invasive approach.
Pavia, PaviaAges 18 years+ - NCT07596576Recruiting
Slowing aging through comprehensive health screening and interventions
This study helps healthy older adults understand their biological age—how old your body actually is—and tests personalized interventions to help you age more slowly and stay healthier longer. Researchers will perform detailed health assessments and then guide you through targeted treatments based on your individual aging profile.
Ramat Gan, Tel AvivAges 50 years+ - NCT07597031Recruiting
Digital Lifestyle Platform for People Leaving Hospital Rehab
This study tests whether a smartphone or tablet app can help people stay healthy and active after leaving rehabilitation. The app guides you through daily activities and healthy habits to support your recovery at home.
Bern, Canton of BernAges 18 years+ - NCT07598630Recruiting
Two surgical approaches for severe hemorrhoids
This study compares two different surgical methods for treating severe hemorrhoids (third and fourth degree). The SHAPE procedure is a newer technique being tested against the traditional Milligan-Morgan approach to see which works better for pain relief and recovery.
Cairo, Al-Manial, Cairo, EgyptAges 18 years+ - NCT07599241Recruiting
Exercise Program for Older Women With Thyroid, Eye, and Liver Conditions
This study tests whether a physical activity program can help older women manage three common conditions together: an underactive thyroid, high eye pressure (glaucoma), and fatty liver disease. Researchers want to see if exercise improves symptoms and overall health when addressing multiple conditions at once.
Dokki, Giza GovernorateAges 65–75 - NCT07599813RecruitingPhase 2
Testing camoteskimab for moderate-to-severe eczema
This study tests a new medication called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema) that hasn't responded well to creams alone. The drug works by targeting a protein in the body that causes eczema symptoms like itching and inflammation.
Birmingham, AlabamaAges 18–65 - NCT07600008RecruitingEarly Phase 1
Probiotics as a supplement for reflux disease management
This early-stage trial tests whether a probiotic supplement can help support treatment of reflux disease (GERD) in patients already taking a standard reflux medication. Researchers want to see if adding probiotics might improve symptoms or overall digestive health.
OlomoucAges 40–55 - NCT07601282Recruiting
Predicting Incontinence Risk After Pelvic Floor Surgery
This study helps doctors predict which patients may develop urinary incontinence (leakage) after surgery to repair pelvic organ prolapse (when pelvic organs drop into the vaginal canal). By identifying risk factors early, doctors may be able to better prepare patients and prevent this complication.
Shanghai, Shanghai MunicipalityAges 20–90 - NCT07601763Recruiting
Pulsed Field Ablation for Atrial Fibrillation Treatment
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07601867Recruiting
Dapagliflozin to improve heart function after bypass surgery
This trial tests whether a diabetes medication called dapagliflozin can help improve how well the right side of your heart works after off-pump coronary artery bypass grafting surgery (a way to reroute blood around blocked heart arteries). The goal is to see if this drug reduces strain on your heart during recovery.
Pyatigorsk, Stavropol KrayAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,739 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.